Stock Track | HealthStream Plunges 13.9% Pre-Market on Q1 Earnings Miss and Lowered 2025 Guidance

Stock Track
06 May

HealthStream (NASDAQ: HSTM) shares are set to tumble 13.9% in pre-market trading on Tuesday following the release of disappointing first-quarter results and reduced full-year guidance. The healthcare technology platform provider reported earnings that fell short of analyst expectations, signaling potential challenges in its business operations.

For the first quarter ended March 31, 2025, HealthStream reported earnings per share (EPS) of $0.14, missing the consensus estimate of $0.16 by 12.5%. This represents a significant decline from the $0.17 per share earned in the same period last year. The company's quarterly revenue came in at $73.49 million, up 1% year-over-year but falling short of the $74.93 million analysts had projected.

Adding to investor concerns, HealthStream lowered its full-year 2025 revenue guidance to a range of $297.5 million to $303.5 million, down from its previous forecast. The company cited several factors impacting its performance, including a $1.7 million reduction from attrition in legacy applications, a $0.9 million decrease in perpetual license sales, and a $0.6 million reduction due to customer bankruptcies. Despite these headwinds, HealthStream reported some growth across its portfolio of solutions, which partially offset the negative impacts. The revised outlook and missed earnings have likely contributed to the sharp pre-market decline in the company's stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10